Voyager Therapeutics VYGR
NASDAQ VYGR
$2.45 -0.22 (-8.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Asset Writedowns and Impairment (2024)

Updated

Voyager Therapeutics (VYGR) recorded Asset Writedowns and Impairment of $24,000 in Q4 2024.

Analysis

Voyager Therapeutics (VYGR) Asset Writedowns and Impairment (2024) Analysis & Trends

For FY2024, Voyager Therapeutics reported Asset Writedowns and Impairment of $2.8 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Voyager Therapeutics 150.12 Mn -513.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 24,000.00
API Access

Voyager Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=VYGR&period=max&api_key=YOUR_API_KEY